Bone Involvement in Primary Hyperparathyroidism and Changes After Parathyroidectomy
| Autor: | Lars Rejnmark, Peer Christiansen, Lars Rolighed |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Parathyroidectomy
Bone mineral medicine.medical_specialty Hypercalcaemia endocrine system diseases Endocrine and Autonomic Systems business.industry Endocrinology Diabetes and Metabolism medicine.medical_treatment Parathyroid hormone medicine.disease Bone resorption Bone remodeling Endocrinology Internal medicine Medicine Metabolie Bone Disorders business Reduction (orthopedic surgery) Primary hyperparathyroidism |
| Zdroj: | Rolighed, L, Rejnmark, L & Christiansen, P M 2013, ' Bone involvement in primary hyperparathyroidism and changes after parathyroidectomy ', U S Endocrinology, vol. 9, no. 2 . |
| Popis: | Parathyroid hormone (PTH) is produced and secreted by the parathyroid glands and has primary effects on kidney and bone. During the pathological growth of one or more parathyroid glands, the plasma level of PTH increases and causes primary hyperparathyroidism (PHPT). This disease is normally characterised by hyperparathyroid hypercalcaemia. In PHPT a continuously elevated PTH stimulates the kidney and bone causing a condition with high bone turnover, elevated plasma calcium and increased fracture risk. If bone resorption is not followed by a balanced formation of new bone, irreversible bone loss may occur in these patients. Medical treatment can help to minimise the loss of bone but the cure of PHPT is by parathyroidectomy. After operation, bone mineral density increases during the return to normal bone metabolism. Supplementation with calcium and vitamin D after operation may improve the normalisation to normal bone metabolism with a secondary reduction in fracture risk. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|